Helix Biomedix Inc

NEW
OTCPK:HXBM (USA)  
$ 1.79 (0%) 11:08 PM EST
At Loss
Market Cap:
$ 402.00K
Enterprise V:
$ 402.00K
Volume:
0
Avg Vol (2M):
125.00
Trade In:
Volume:
0
At Loss
Avg Vol (2M):
125.00

Business Description

Description
Helix Biomedix Inc is a Delaware-based biopharmaceutical company that focuses on the early-stage development of peptide-based therapeutics for dermatology and skin health. The Company is in the preclinical stage, advancing a rare disease drug program for xeroderma pigmentosum, and plans to seek orphan drug designation before entering clinical development. Leveraging its proprietary peptide technology, Helix BioMedix aims to address unmet needs in rare dermatological conditions and has a history of developing patented bioactive peptides for topical personal care use.

Financial Strength

Name Current Vs Industry Vs History

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI
99.95
9-Day RSI
97.67
14-Day RSI
88.77
3-1 Month Momentum %
79
6-1 Month Momentum %
-10.5
12-1 Month Momentum %
-75.07

Liquidity Ratio

Name Current Vs Industry Vs History

Dividend & Buy Back

Name Current Vs Industry Vs History

Profitability Rank

Name Current Vs Industry Vs History
FCF Margin %
-88
OCF Margin %
-88

GF Value Rank

Name Current Vs Industry Vs History

Financials

HXBM's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:HXBM

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017

Helix Biomedix Inc Executives

Details

GF Valueâ„¢

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 2.066
EPS (TTM) ($) -15.001
Beta 2.4323
3-Year Sharpe Ratio -0.72
3-Year Sortino Ratio -0.95
Volatility % 124.84
14-Day RSI 88.77
14-Day ATR ($) 0.001928
20-Day SMA ($) 1.79
12-1 Month Momentum % -75.07
52-Week Range ($) 1 - 7.18
Shares Outstanding (Mil) 0.22

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 0
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Helix Biomedix Inc Filings

Filing Date Document Date Form
No Filing Data

Helix Biomedix Inc Stock Events

Financials Calendars
Event Date Price ($)
0.003333:1 Stock Split 2013-01-03 60.00 (+100.00%)
Show
Entries

Helix Biomedix Inc Frequently Asked Questions

What is Helix Biomedix Inc(HXBM)'s stock price today?
The current price of HXBM is $1.79. The 52 week high of HXBM is $7.18 and 52 week low is $1.00.
When is next earnings date of Helix Biomedix Inc(HXBM)?
The next earnings date of Helix Biomedix Inc(HXBM) is .
Does Helix Biomedix Inc(HXBM) pay dividends? If so, how much?
Helix Biomedix Inc(HXBM) does not pay dividend.

Guru Commentaries on OTCPK:HXBM

No articles.

Press Release

Subject Date
No Press Release

Articles on Helix Biomedix Inc

No articles.

Headlines

See More
  • 1
No news.
  • 1